Literature DB >> 11641447

Repeated antenatal glucocorticoid exposure and the developing brain.

O Dammann1, S G Matthews.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11641447     DOI: 10.1203/00006450-200111000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  12 in total

1.  Prenatal dexamethasone augments the neurobehavioral teratology of chlorpyrifos: significance for maternal stress and preterm labor.

Authors:  Edward D Levin; Marty Cauley; Joshua E Johnson; Ellen M Cooper; Heather M Stapleton; P Lee Ferguson; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2013-10-28       Impact factor: 3.763

2.  Prenatal dexamethasone augments the sex-selective developmental neurotoxicity of chlorpyrifos: implications for vulnerability after pharmacotherapy for preterm labor.

Authors:  Theodore A Slotkin; Jennifer Card; Alice Infante; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2013-02-14       Impact factor: 3.763

3.  Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: Terbutaline and dexamethasone, separately and together.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2018-03-07       Impact factor: 4.221

4.  Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-08-19       Impact factor: 4.077

5.  Prenatal dexamethasone, as used in preterm labor, worsens the impact of postnatal chlorpyrifos exposure on serotonergic pathways.

Authors:  Theodore A Slotkin; Jennifer Card; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2013-11-23       Impact factor: 4.077

6.  Fetal glucocorticoid exposure is associated with preadolescent brain development.

Authors:  Elysia Poggi Davis; Curt A Sandman; Claudia Buss; Deborah A Wing; Kevin Head
Journal:  Biol Psychiatry       Date:  2013-04-21       Impact factor: 13.382

7.  Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthood.

Authors:  Abayomi A Adigun; Nicola Wrench; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-10-20       Impact factor: 3.763

8.  Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2015-09-28       Impact factor: 4.221

9.  Does growth impairment underlie the adverse effects of dexamethasone on development of noradrenergic systems?

Authors:  Theodore A Slotkin; Ashley Ko; Frederic J Seidler
Journal:  Toxicology       Date:  2018-06-20       Impact factor: 4.221

10.  A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis.

Authors:  Arjan Scheepens; Marjo van de Waarenburg; Daniël van den Hove; Carlos E Blanco
Journal:  J Physiol       Date:  2003-08-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.